StonvexLoading…
StonvexStonvexStonvexCore line items from SUNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $71.91M | $56.86M | $79.63M | $27.52M |
Operating Income | $-1.67M | $-12.32M | $-7.47M | $-10.45M |
Net Income | $-10.89M | $-15.85M | $-8.13M | $-10.35M |
EPS (Diluted) | $-4.38 | $-10110.93 | $-611.55 | $-4.04 |
Total Assets | $48.24M | $45.71M | $58.17M | $74.70M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $7.18M | $839.27K | $3.58M | $2.19M |
Free Cash Flow OCF − CapEx | $906.38K | $-6.34M | $-1.32M | $-7.69M |
Shares Outstanding | 3.41M | 9.34K | 13.66K | 9.92M |